Johannsen Jessika, Bierhals Tatjana, Deindl Philipp, Hecher Laura, Hermann Katharina, Hempel Maja, Kloth Katja, Denecke Jonas
Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Pediatr Genet. 2019 Dec;8(4):222-225. doi: 10.1055/s-0039-1685501. Epub 2019 Apr 20.
Recently, mutations in the gene were described as a novel cause for vitamin B6-responsive epilepsy. We report the outcome in case of a male adolescent with a novel homozygous missense variant in who was never treated with pyridoxine until the age of 16 years. He presented with only mild cognitive impairment and an early-onset, well-controlled epilepsy. In our patient, excessive seizure clusters and anxiety states occurred intermittently, suggesting that the combination might be a hallmark in untreated patients. Thus, mutations in should be addressed even in adolescent patients with only mild learning disabilities and relatively good seizure control over the years.
最近,该基因的突变被描述为维生素B6反应性癫痫的一种新病因。我们报告了一名男性青少年的病例结果,该患者存在一种新的纯合错义变体,在16岁之前从未接受过吡哆醇治疗。他仅表现出轻度认知障碍和早发性、控制良好的癫痫。在我们的患者中,癫痫发作簇和焦虑状态间歇性出现,这表明这种组合可能是未治疗患者的一个标志。因此,即使是多年来仅有轻度学习障碍且癫痫控制相对良好的青少年患者,也应考虑该基因突变的可能性。